This collection examines issues related to reproductive health, including the legality of reproductive services (reproductive rights), access to those services (reproductive health), and how societal factors such as race or social status impact access to and decisions about reproductive health (reproductive justice). This includes everything from contraception and comprehensive sex education, to abortion and pre-natal and pregnancy care, as well as other issues that inform a person’s full reproductive autonomy. This special collection brings together knowledge and insights from organizations addressing reproductive health related issues and explores the impact foundations and nonprofits are having on this work.

More ways to engage:
- Add your organization's content to this collection.
- Send us content recommendations.
- Easily share this collection on your website or app.

Photo by choja licensed through Getty Images

Search this collection

Clear all

5 results found

reorder grid_view

Abortion in the U.S. Dashboard

January 1, 2023

On June 24, 2022, the Supreme Court overturned Roe v. Wade, eliminating the federal constitutional standard that had protected the right to abortion. Without any federal standard regarding abortion access, states will set their own policies to ban or protect abortion. The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. Be sure to click on the buttons or scroll down to see all the content. It will be updated as new information is available.

KFF Health Tracking Poll: Views on and Knowledge about Abortion in Wake of Leaked Supreme Court Opinion

June 9, 2022

For decades, KFF polling has provided insights into national and state-level reproductive health care policy including multiple public opinion polls examining the experiences and attitudes of the general public as well as the group most impacted by such policies – women between the ages of 18 and 49. This latest KFF poll was fielded the week following the leak of a draft of the U.S. Supreme Court opinion on Dobbs v. Jackson Women's Health Center. If the final ruling in the case resembles the leaked draft, the Court would overturn Roe v. Wade and end the constitutional right to abortion. This analysis examines the public's attitudes and understanding of the future of reproductive health and abortion access in the U.S. and looks at the role abortion and a decision on Dobbs may play in the upcoming midterm elections this November.

Abortion at SCOTUS: Dobbs v. Jackson Women’s Health

May 4, 2022

Abortion is among the most contentious issues in the country today. On December 1st, the Supreme Court will hear the first abortion case since Justice Amy Coney Barrett was seated and cemented a solid 6-3 conservative majority on the bench. The case under consideration, Thomas E. Dobbs, State Health Officer of the Mississippi Department of Health v. Jackson Women's Health Organization, involves a Mississippi law banning all abortions over 15 weeks gestational age except in medical emergencies and in the case of severe fetal abnormality. In this case, Mississippi is asking the Court to overturn the long-standing precedent of Roe v. Wade. While the Supreme Court has considered other abortion cases involving state regulations, this is the first case that the high court has taken in which a state is directly asking the Court to overturn the constitutional right to abortion. This issue brief provides background on the legal challenges to the Mississippi law in the context of the Supreme Court abortion precedents, addresses the intersections with the litigation that has arisen from S.B. 8, the Texas 6-week abortion ban, and explains the potential outcomes and how they could impact access to abortion around the country.

The Intersection of State and Federal Policies on Access to Medication Abortion Via Telehealth

February 7, 2022

The Supreme Court's impending ruling on Dobbs v. Jackson Women's Health Organization has renewed attention to medication abortion as a way to expand access to abortion in states protective of abortion access and to preserve access to abortion in states that seek to enact restrictive laws. In recent years, telehealth has been explored and tested as a way to expand access to medication abortion, with growing importance for communities with few abortion providers. This approach has gained additional attention given the need to limit in-person contact during the COVID-19 pandemic.However, expanding access to medication abortion via telehealth has been limited by a Food and Drug Administration (FDA) restriction that had permitted only certified clinicians to dispense mifepristone at a health care setting.This brief outlines the intersection of federal policy regarding dispensing medication abortion with state laws regulating the provision of abortion services and mifepristone dispensing via telehealth and considers the implications of the recent FDA change in different states.

Women's Sexual and Reproductive Health Services: Key Findings from the 2020 KFF Women's Health Survey

April 21, 2021

Sexual and reproductive health is an integral part of women's overall health. Access to these services is shaped by a broad range of factors including coverage and affordability, national and state policies, availability of care, health provider characteristics, as well as individual preferences and experiences. For many women, the Affordable Care Act (ACA) improved access to sexual and reproductive health care by expanding pathways to Medicaid eligibility and making private insurance more affordable. The ACA also required private health insurance plans to cover many recommended preventive services without any patient cost-sharing, such as sexually transmitted infection counseling and screening and all 18 FDA-approved contraceptive methods. While the ACA has expanded sexual and reproductive health care, state and federal policy actions in recent years have resulted in more limited access to comprehensive sexual and reproductive health care, including abortion referrals and services, particularly for women who depend on publicly supported health care providers and clinics.Access in the past year has also been undoubtedly affected by the COVID-19 pandemic, which has forced providers to find ways to make contraceptive and STI services available via telehealth or through minimal contact, like no-test medication abortions. There is increasing interest in expanding efforts to allow pharmacists to prescribe birth control, gain FDA approval for over-the-counter oral contraception without a prescription, and expanding access to contraception through smartphone apps or online platforms that no longer require a visit to a brick-and-mortar clinic or doctor's office.While the system is undergoing constant change, the perspectives and experiences of women in obtaining sexual and reproductive health care can help to shape the next generation of policies and programs. This brief provides a window into some of those voices and perspectives by presenting selected findings from the 2020 KFF Women's Health Survey, a nationally representative survey of women conducted in November/December of 2020. The survey covered a wide range of topics related to women's coverage, use, access, and experiences with the health care system. This brief presents survey findings on coverage and use of reproductive and sexual health services among different subgroups of 2,695 women ages 18 to 49.